Center for Klinisk Metabolisk Forskning

Publikation

Publikationer pr. år 2015 2020 2021 2022 2023

• 141 Tidsskriftartikel
• 67 Konferenceabstrakt til konference
• 19 Review
• 16 Ph.d.-afhandling
• 15 Mere
  • 5 Konferenceabstrakt i tidsskrift
  • 3 Letter
  • 2 Bidrag til bog/antologi
  • 2 Kommentar/debat
  • 1 Bog
  • 1 Leder
  • 1 Patent

Publikationer pr. år

Publikationer pr. år

Søgeresultater

• 2022

  GIP infusion acutely decreases blood pressure and increases heart rate in men with type 2 diabetes, concomitantly with increased proatrial natriuretic peptide levels

  Sorum, N. M., Gasbjerg, L. S., Andersen, M. M., Heimburger, S. M. N., Krogh, L. S. L., Holst, J. J., Vilsboll, T., Lund, A., Terzic, D., Bergmann, N. C. & Knop, F. K., sep. 2022, s. S283-S284.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The effects of glucose-dependent insulinotropic polypeptide (GIP) on human islet function, transcriptome and cytokine-induced inflammation and apoptosis

  Henriksen, K., Jørgensen, A., Kaur, S., Knop, F. K. & Størling, J., jun. 2022.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

  • Transcriptome 100%
  • Peptides 69%
  • Glucose 68%
  • Cytokines 67%
  • Apoptosis 66%
• 2021

  Acute Fluctuations in Plasma Glucose Affect Echocardiographic-Derived Measures of Systolic Function in Patients with Type 1 Diabetes

  Andreasen, C. R., Andersen, A., Hagelqvist, P. G., Abelin, K. U., Lauritsen, J. V., Jørgensen, P., Engberg, S., Faber, J. O., Holst, J. J., Pedersen-Bjergaard, U., Knop, F. K. & Vilsbøll, T., 25 jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Formidling

• Acute Physiological Effects of Gastric Aspiration for the Treatment of Obesity

  Gether, I. M., Jensen, M. M., Nexoe-Larsen, C., Jorsal, T., Gasbjerg, L. S., Naver, L. P. S., Holst, J. J., Rehfeld, JF., Vilsboll, T. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• A novel, long-acting dual agonist for GIPR/GLP-1R, HISHS-2001, demonstrates effects on HbA1c and weight loss in the db/db mouse model of type 2 diabetes

  Thennati, R., Burade, V., Garcia-Ocana, A., Pratley, R. E., Rutter, G. A., Vilsboll, T. & Thorens, B., sep. 2021, s. 242-242.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Associations of hypoglycaemia and glycaemic variability with cardiac arrhythmias using a long-term monitoring approach in insulin-treated patients with type 2 diabetes

  Andersen, A., Bagger, J. I., Sorensen, S. K., Baldassarre, M. P. A., Pedersen-Bjergaard, U., Forman, J. L., Gislason, G., Lindhardt, T. B., Knop, F. K. & Vilsboll, T., sep. 2021, s. 135-135.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Effects of Exogenous Secretin on Postprandial Plasma Glucose and Lipids and Gallbladder Motility and Hemodynamics in Man

  Bentzen, M. J., Heimburger, S. M. N., Hartmann, B., Holst, J. J., Christensen, M. B. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Effects of Liraglutide in T1D by Baseline Anthropometrics in ADJUNCT One and Two

  Dejgaard, T. F., Bardtrum, L., Christiansen, E., Kreiner, F., Madsbad, S., Von Herrath, M. G. S. R., Von Scholten, B. J. & Mathieu, C., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Exogenous LEAP2 improves postprandial glucose tolerance and reduces ad libitum food intake in men

  Hagemann, C. A., Jensen, M. S., Holm, S., Gasbjerg, L. S., Christensen, M. B., Heimburger, S. M. N., Dela, F., Vilsboll, T., Holst, B. & Knop, F. K., sep. 2021, s. 23-23.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Exogenous secretin decreases ad libitum food intake and exhibits a biphasic effect on supraclavicular brown adipose tissue activity in healthy men

  Bentzen, M. J., Heimburger, S. M. N., Hartmann, B., Holst, J. J., Christensen, M. B. & Knop, F. K., sep. 2021, s. 211. 1 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Exogenous Secretin Decreases Energy Intake and Exerts a Bimodular Effect on Postprandial Brown Adipose Tissue Activation in Man

  Heimburger, S. M. N., Bentzen, M. J., Hartmann, B., Holst, J. J., Christensen, M. B. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Five years of treatment with liraglutide improves glucose tolerance in women with prior gestational diabetes, but effects are lost after washout

  Andersen, E. S., Foghsgaard, S., Vedtofte, L., Pedersen, M. H., Forman, J. L., Mathiesen, E. R., Svare, J. A., Holst, J. J., Clausen, T. D., Damm, P., Knop, F. K. & Vilsboll, T., sep. 2021, s. 154. 1 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Glucose -Dependent Insulinotropic Polypeptide (GIP) Contributes Substantially to the Improved Beta -Cell Function during Sitagliptin Treatment in Persons with Type 2 Diabetes

  Stensen, S., Gasbjerg, L. S., Rosenkilde, M. M., Hartmann, B., Vilsboll, T., Holst, J. J., Christensen, M. B. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Glucose-dependent insulinotropic polypeptide (GIP) contributes to sitagliptin-mediated improvement of beta cell function in patients with type 2 diabetes

  Stensen, S., Gasbjerg, L. S., Rosenkilde, M. M., Hartmann, B., Vilsboll, T., Holst, J. J., Christensen, M. B. & Knop, F. K., sep. 2021, s. 95-95.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• GLYCAEMIC MARKERS IN PATIENTS WITH TYPE 2 DIABETES UNDERGOING HAEMODIALYSIS EVALUATED BY LONG-TERM CONTINUOUS GLUCOSE MONITORING

  Bomholt, T., Rix, M., Almdal, T. P., Knop, F. K., Rosthoj, S., Heinrich, N. S., Jorgensen, M., Larsson, A., Hilsted, L., Feldt-Rasmussen, B. & Hornum, M., maj 2021, s. 371-371.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Glycaemic variability of oral semaglutide vs empagliflozin: a post-hoc analysis of PIONEER 2

  Montanya, E., Abildlund, M. T., Kreiner, E. B., Mosenzon, O., Rosenlund, S. & Vilsboll, T., sep. 2021, s. 257-257.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Hypoglycemia, Glycemic Variability, and Risk of Cardiac Arrhythmias in Insulin-Treated Patients with Type 2 Diabetes

  Andersen, A., Bagger, J. I., Sorensen, S. K., Baldassarre, M. P. A., Pedersen-Bjergaard, U., Forman, J., Gislason, G., Lindhardt, T. B., Knop, F. K. & Vilsboll, T., jun. 2021, s. 45-OR.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Increased glucagon sensitivity in totally pancreatectomised patients

  Rix, I., Lund, A., Garvey, L. F., Owen, K., Hansen, C., van Hall, G., Holst, J. J., Vilsboll, T. & Knop, F. K., sep. 2021, s. 118-119. 2 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Increased Glucagon Sensitivity in Totally Pancreatectomized Patients

  Rix, I., Lund, A., Garvey, L. F., Owen, K., Hansen, C., Van Hall, G., Holst, J. J., Vilsboll, T. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Increased Glucagon Sensitivity in Totally Pancreatectomized Patients

  Rix, I., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• In Women with Prior Gestational Diabetes Mellitus, the Glucagon-Like-Peptide-1 Receptor Agonist Liraglutide Improves Glucose Tolerance Irrespective of Body Weight Loss after Five Years of Treatment, but Effects Are Lost after Wash-Out

  Andersen, E. S., Foghsgaard, S., Vedtofte, L., Pedersen, M. H., Forman, J., Mathiesen, E. R., Svare, J., Holst, J. J., Clausen, T. D., Damm, P., Knop, F. K. & Vilsboll, T., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

  Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, B., Knudsen, L. B., Jacobsen, L. V., Rehfeld, J. F., Holst, J. J., Vilsboll, T., Sonne, D. P. & Knop, F. K., sep. 2021, s. 94-94. 1 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Mobile health application as a real-world data resource: self-recorded weight reduction with once-weekly semaglutide

  Bodholdt, U., Birot, S., Catarig, A. -M., Erhan, U. & Knop, F. K., sep. 2021, s. 232-233.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Neutrophil-to-lymphocyte ratio predicts cardiovascular events in patients with type 2 diabetes: post hoc analysis of SUSTAIN 6 and PIONEER 6

  Verma, S., Husain, M., Madsen, C. M., Leiter, L. A., Rajan, S., Vilsboll, T., Rasmussen, S. & Libby, P., sep. 2021, s. 253-254.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• No effect of curcumin on liver fat content in obese individuals

  Bidragets oversatte titel: Ingen effekt af curcumin på leverens fedtindhold hos svært overvægtige individerHellmann, P. H., Bagger, J. I., Holst, J. J., Chabanova, E., Vilsbøll, T. & Knop, F. K., 12 nov. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Six-day sc GIP infusion increases plasma NEFA without altering the adipose tissue transcriptome, GIPR levels or plasma markers of inflammation in patients with type 1 diabetes

  Heimburger, S. M. N., Hoe, B., Nielsen, C. N., Hartmann, B., Holst, J. J., Dela, F., Overgaard, J., Storling, J., Vilsboll, T., Dejgaard, T. F., Pyke, C., Christensen, M. B. & Knop, F. K., sep. 2021, s. 258-258. 1 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Six-Day Subcutaneous GIP Infusion Increases Circulating Free Fatty Acids without Altering the Adipose Tissue Transcriptome, Adipocyte GIP Receptor Levels, or Circulating Inflammation Markers in Patients with Type 1 Diabetes

  Heimburger, S. M. N., Hoe, B., Nielsen, C. N., Hartmann, B., Holst, J. J., Dela, F., Overgaard, A. J., Storling, J., Vilsboll, T., Dejgaard, T. F., Pyke, C., Christensen, M. B. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The Glucagon-Like Peptide-1 Analog, Liraglutide Is a Safe and Effective Treatment of Bile Acid Malabsorption: A Proof of Concept Study

  Karhus, M. L., Bronden, A., Forman, J., Haaber, A., Langholz, E., Vilsboll, T., Sonne, D. P. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The Glucagonotropic Effect of GLP-2 during Hypoglycemia, Euglycemia, and Hyperglycemia in Healthy Men: A Randomized, Double-Blind, Placebo-Controlled,Crossover Study

  Hansen, N. L., Magnussen, T., Holst, J. J., Hartmann, B., Christensen, M. B., Lund, A. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The glucose-lowering effect of the bile acid sequestrant sevelamer in patients with type 2 diabetes is not mediated by glucagon-like peptide 1

  Nerild, H. H., Bronden, A., Haddouchi, A. E., Holst, J. J., Sonne, D. P., Vilsboll, T. & Knop, F. K., sep. 2021, s. 217-217. 1 s.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The Glucose-Lowering Effect of the Bile Acid Sequestrant Sevelamer Is Not Mediated by Glucagon-Like Peptide-1

  Nerild, H. H., Bronden, A., El Haddouchi, A., Holst, J. J., Sonne, D. P., Vilsboll, T. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• The impact of acute fluctuations in plasma glucose on echocardiographic derived measures of systolic function in patients with type 1 diabetes

  Andreasen, C. R., Andersen, A., Hagelqvist, P. G., Abelin, K. U., Lauritsen, J. V., Jørgensen, P. G., Engberg, S., Faber, J. O., Holst, J. J., Pedersen-Bjergaard, U., Knop, F. K. & Vilsbøll, T., sep. 2021, s. 135-136.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Time spent in glycaemic control after initiating treatment with oral semaglutide vs empagliflozin: an exploratory analysis of the PIONEER 2 trial

  Knop, F. K., Cariou, B., Christiansen, E., Davies, A. L., Montanya, E., Abildlund, M. T. & Rosenstock, J., sep. 2021, s. 249-250.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Transcriptional Profiling of the Intestinal Serotonin System in Individuals with Type 2 Diabetes and Healthy Individuals

  Legart, C., Hagemann, C. A., Ellegaard, A. M., Keating, D., Jorsal, T. & Knop, F. K., jun. 2021.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review
• 2020

  Acute Changes in Plasma Glucose Have Impact on Left Ventricular Systolic Function in Insulin-Treated Patients with Type 2 Diabetes

  Andersen, A., Jorgensen, P. G., Bagger, J. I. . S., Baldassarre, M. P. A., Christensen, M. B., Abelin, K. U., Pedersen-Bjergaard, U., Holst, J. J., Lindhardt, T. B., Knop, F. K. & Vilsboll, T., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• A Novel Long-Acting GLP-1 Agonist (GL0034) Demonstrates Remarkable Efficacy on HbA1c, Weight Loss, and Triglycerides in a Model of Type 2 Diabetes, the db/db Mouse

  Thennati, R., Burade, V. S., Vilsboll, T., Thorens, B. & Rutter, G. A., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Cardiovascular effects of high-dose glucagon: a randomised clinical trial

  Petersen, K. M., Bogevig, S., Riis, T., Andersson, N. A. W., Dalhoff, K. P., Holst, J. J., Knop, F. K., Faber, J., Petersen, T. S. & Christensen, M. B., sep. 2020, s. S231-S231.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Counterregulatory responses to hypoglycaemia in totally pancreatectomised patients

  Baekdal, M., Lund, A., Baldassare, MPA., Rose, K., Egholk, J., Christensen, M. B., Hansen, C. P., Storkholm, J. H., Faber, J., Hartmann, B., Holst, J. J., Vilsbøll, T. & Knop, F. K., sep. 2020, s. S95-S95.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Counterregulatory Responses to Hypoglycemia in Totally Pancreatectomized Patients

  Baekdal, M., Lund, A. B., Baldassarre, M. P. A., Egholk, J. I., Rose, K., Hansen, C., Storkholm, J. H., Christensen, M. B., Hartmann, B., Faber, J., Holst, J. J., Vilsboll, T. & Knop, F. K., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Dasiglucagon ameliorates postprandial hypoglycaemia after RouxEn-Y gastric bypass

  Nielsen, C. K., Ohrstrom, C. C., Kielgast, U. L., Hansen, D. L., Lund, A., Vilsboll, T. & Knop, F. K., sep. 2020, s. S356-S357.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Dasiglucagon Ameliorates Postprandial Hypoglycemia after Roux-en-y Gastric Bypass

  Nielsen, C. K., Oehrstroem, C., Kielgast, U., Hansen, D. L., Lund, A., Vilsboll, T. & Knop, F. K., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Development of an evidence-based tool to facilitate individualised treatment decisions for patients with type 2 diabetes in the clinic

  Buse, J. B., Harring, S., Holst, I., Kahkoska, A. R., Knop, F. K., Kvist, K. & Pratley, R., sep. 2020, s. S376-S377.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Development of an Evidence-Based Tool to Facilitate Individualized Treatment in the Clinic for Patients with Type 2 Diabetes

  Kahkoska, A. R., Buse, J. B., Harring, S., Holst, I., Knop, F. K., Kvist, K. & Pratley, R. E., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Downregulation of HMGCS2 Expression in Small Intestinal Mucosa Biopsies after Roux-en-Y Gastric Bypass Surgery: A Possible Contributor to GLP-1 Hypersecretion?

  Legart, C., Jorsal, T., Hagemann, C. A., Worm, D., Juhl, C. B., Andries, A. R., Zhang, C., Vrang, N., Rigbolt, K., Jelsing, J., Vilsboll, T. & Knop, F. K., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Empagliflozin Attenuates Fasting and Postprandial Hyperglycemia in Totally Pancreatectomized Patients: A Randomized, Double-Blinded, Placebo-Controlled Crossover Trial

  Baekdal, M., Lund, A., Nielsen, S. W., Storkholm, J. H., Hansen, C., Vilsboll, T. & Knop, F. K., jun. 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Empagliflozin decreases fasting and postprandial hyperglycaemia in totally pancreatectomised patients: a randomised, double-blinded, placebo-controlled study

  Lund, A., Baekdal, M., Nielsen, S. W., Hansen, C. P., Storkholm, J. H., Hartmann, B., Holst, J. J., Vilsboll, T. & Knop, F. K., sep. 2020, s. S276-S276.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Gastrointestinal adverse events with once-weekly semaglutide: risk predictors and effect on semaglutide response

  Knop, F. K., Harring, S., Holst, I., Kvist, K., Lingvay, I. & Vilsboll, T., sep. 2020, s. S290-S291.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• GIP infusion in patients with type 1 diabetes seems to attenuate post-prandial glucose excursions after prandial insulin over-dose and physical activity

  Hoe, B., Heimburger, S. M. N., Gasbjerg, L. S., Lanng, A. R., Lynggaard, M. B., Hartmann, B., Holst, J. J., Vilsboll, T., Lund, A., Engberg, S., Dejgaard, T. F., Christensen, M. B. & Knop, F. K., sep. 2020, s. S117-S117.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › peer review

• Glucose-dependent insulinotropic polypeptide (GIP) increases glucagon secretion from human islets under hypoglycaemic conditions in vitro

  Jørgensen, A., Egeskov, M., Knop, F. K. & Størling, J., 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning

• Glucose-dependent insulinotropic polypeptide (GIP) increases glucagon secretion from human islets under hypoglycemic conditions in vitro.

  Jørgensen, A., Egeskov, M., Knop, F. K. & Størling, J., 2020.

  Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning